Fostering Epilepsy Care News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Fostering epilepsy care. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Fostering Epilepsy Care Today - Breaking & Trending Today

BIAL Takes the Lead in Europe for the Commercialisation of Epilepsy Treatment, Zebinix (eslicarbazepine acetate), Expanding Neurology Footprint

(2)
Press Release for European Medical and Trade Media Only
BIAL announces the end of the licence agreement established in 2009. BIAL takes the lead for the marketing and distribution of Zebinix
(eslicarbazepine acetate) in Europe. Eslicarbazepine acetate is a once-daily anti-epileptic used to treat epilepsy patients with focal seizures (partial-onset seizures)
For over a decade, BIAL and Eisai have had an agreement in place for Eisai to market, promote, and distribute eslicarbazepine acetate in Europe. Following the end of this partnership, BIAL will take the lead for the ongoing marketing, promotion and distribution in Europe. This move reinforces its continued commitment to and ongoing investment in neurological conditions. ....

Susana Vasconcelos , Almeida Bastos , Biochem Biophys , Kostenloser Wertpapierhandel , Chrissie Hartgill , Makara Health , World Health Organization , Health Press , Press Release , European Medical , Trade Media , Chief Commercial Officer , Vice President , Global Neurology Business Unit , Fostering Epilepsy Care , Last Accessed January , World Health Organization Report , Nat Rev Dis Primers , United Kingdom , Health Press Limited , சுசானா வாஸ்கான்செலோஸ் , அல்மேடா பாஸ்டோஸ் , மகர ஆரோக்கியம் , உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் , ஆரோக்கியம் ப்ரெஸ் , ப்ரெஸ் வெளியீடு ,